<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Blog Post: T-Cell Invasion	</title>
	<atom:link href="https://visikol.com/blog/2019/05/02/blog-post-t-cell-invasion/feed/" rel="self" type="application/rss+xml" />
	<link>https://visikol.com/blog/2019/05/02/blog-post-t-cell-invasion/</link>
	<description>Advanced Drug Discovery and Bioimaging Services</description>
	<lastBuildDate>Mon, 06 Dec 2021 14:16:41 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: When Will Multiplex Tissue Imaging Start Being Used as a Clinical Tool?		</title>
		<link>https://visikol.com/blog/2019/05/02/blog-post-t-cell-invasion/#comment-13250</link>

		<dc:creator><![CDATA[When Will Multiplex Tissue Imaging Start Being Used as a Clinical Tool?]]></dc:creator>
		<pubDate>Mon, 06 Dec 2021 14:16:41 +0000</pubDate>
		<guid isPermaLink="false">https://visikol.com/?p=7151#comment-13250</guid>

					<description><![CDATA[[&#8230;] factors will decide if a patient is amenable to one treatment or another. For example, the distance T-Cells infiltrate into a tumor might be a unique biomarker for a novel treatment which is a characterization endpoint only [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] factors will decide if a patient is amenable to one treatment or another. For example, the distance T-Cells infiltrate into a tumor might be a unique biomarker for a novel treatment which is a characterization endpoint only [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
